Cure My Disease

Don't miss your cure!

 Log in / Sign up

Radioactive 'Trojan Horse' drug targets liver cancer in first human trial

NCT ID NCT06764316

Recruiting now Disease control Sponsor: Bayer Source: ClinicalTrials.gov ↗

Summary

This is the first study in people to test a new drug, BAY 3547926, for advanced liver cancer (hepatocellular carcinoma). The drug works by delivering a tiny amount of radiation directly to cancer cells to try to shrink tumors. The main goals are to find a safe dose and see how well the drug works, either alone or combined with other treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CIUSSS de l'Estrie-CHUS

    RECRUITING

    Sherbrooke, Quebec, J1H 5N4, Canada

  • Centre Hospitalier de l'Universite de Montreal (CHUM) - Hopi

    RECRUITING

    Montreal, Quebec, H2X 0A9, Canada

  • Imperial College Healthcare NHS Trust | Hammersmith Hospital - Garry Weston Centre

    RECRUITING

    London, W12 0HS, United Kingdom

  • McGill University Health Centre (MUHC) - Research Institute (RI) - McConnell Centre for Innovative Medicine (CIM)

    RECRUITING

    Montreal, Quebec, H4A 3J1, Canada

  • Royal Marsden NHS Foundation Trust | Sutton - Gastrointestinal Unit

    RECRUITING

    Sutton, Surrey, SM2 5PT, United Kingdom

  • Tampere University Hospital, Cancer Center

    RECRUITING

    Tampere, 33520, Finland

  • The START Center for Cancer Care - Madrid - CIOCC - Hospital Universitario Madrid Sanchinarro - Oncologia

    RECRUITING

    Madrid, 28050, Spain

  • Turku University Hospital - Oncology Department

    RECRUITING

    Turku, 20540, Finland

  • UZA - Digestive Oncology

    RECRUITING

    Edegem, 2650, Belgium

  • az Groeninge - Digestive Oncology

    RECRUITING

    Kortrijk, 8500, Belgium

Conditions

Explore the condition pages connected to this study.

HEPATOCELLULAR CARCINOMA